The Hemocompatibility Frontier: Reducing Blood Clot Risk in Artificial Heart Pumps
The Hemocompatibility Frontier: Reducing Blood Clot Risk in Artificial Heart PumpsArtificial heart pumps have revolutionized cardiovascular care, offering life-saving support for patients with end-stage heart failure. Yet one challenge persists: balancing mechanical efficiency with hemocompatibility to minimize blood clot risks. As blood interacts with artificial surfaces, platelet activation...
0 Commenti 0 condivisioni 17 Views 0 Anteprima